Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of the erythropoietin-producing receptor EPHB4 antagonizes androgen receptor overexpression and reduces enzalutamide resistance
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 295, Issue 16, Pages 5470-5483
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2020-03-18
DOI
10.1074/jbc.ra119.011385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of the Wnt/β-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer
- (2018) Zhuangzhuang Zhang et al. CANCER RESEARCH
- Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
- (2018) Yifan Kong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer
- (2018) Qiu Peng et al. Cell Death & Disease
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting receptor tyrosine kinase EphB4 in cancer therapy
- (2017) Yinnan Chen et al. SEMINARS IN CANCER BIOLOGY
- A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
- (2016) Hui Jing et al. CANCER CELL
- KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors
- (2016) Jamie L. McCall et al. MOLECULAR AND CELLULAR BIOLOGY
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer
- (2015) C. Liu et al. CANCER RESEARCH
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer
- (2014) Z. Zhang et al. CANCER RESEARCH
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
- (2013) Andres Jan Schrader et al. EUROPEAN UROLOGY
- A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
- (2013) H. Kuruma et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic targeting of EPH receptors and their ligands
- (2013) Andrew W. Boyd et al. NATURE REVIEWS DRUG DISCOVERY
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- Eph Receptor Signaling and Ephrins
- (2013) E. M. Lisabeth et al. Cold Spring Harbor Perspectives in Biology
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- The many faces and functions of β-catenin
- (2012) Tomas Valenta et al. EMBO JOURNAL
- MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
- (2011) Nagalakshmi Nadiminty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
- (2011) Masaki Shiota et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
- (2010) Georg Martiny-Baron et al. ANGIOGENESIS
- Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells
- (2010) Jonathan W. Astin et al. NATURE CELL BIOLOGY
- The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand
- (2010) Nai-Ying Yang et al. Pigment Cell & Melanoma Research
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
- (2008) R. Hu et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started